Arbeitsbereiche
Early stage researcher at the Institute for Medical Information Processing, Biometry, and Epidemiology (IBE)
Kontakt
and Epidemiology (IBE)
Marchioninistr. 15
81377 München
E-Mail:
yujunxu@ibe.med.uni-muenchen.de
Research Interest
– Reproducibility research
– Multistage model and the application in Acute Myeloid Leukemia (AML)
– Clinical trial methodology
– Predictive modelling
Supervisor(s)
Prof. Dr. Ulrich Mansmann
apl. Prof. Dr. Karsten Spiekermann
Priv. Doz. Dr. Markus Pfirrmann
Curriculum Vitae
EDUCATION
2020 – present Ph.D. Candidate in Medical Research: Epidemiology & Public Health, LMU Munich, Germany
2018 – 2020 MSc in Epidemiology, LMU Munich, Germany
2010 – 2015 Bachelor of Medicine, Shanghai Jiao Tong University, Shanghai, China
WORK EXPERIENCE
2018 – 2020 Research Assistant in Clinical Epidemiology, IBE, Munich, Germany
2015 – 2017 SAS Programmer and Research Assistant, National Center for Cardiovascular Diseases, Beijing, China
Publications
Hasford J, Xu Y. History, Tasks, Legal Basis and Organization of Ethics Committees in Germany. Medicine and Philosophy. 2020 Aug; 41(15):8-11
Mehilli J, Baquet M, Hochholzer W, Mayer K, Tesche C, Aradi D, Xu Y, Thienel M, Gschwendtner S, Zadrozny M, Jochheim D. Randomized Comparison of Intensified and Standard P2Y12-Receptor-Inhibition Before
Elective Percutaneous Coronary Intervention: The SASSICAIA Trial. Circulation: Cardiovascular Interventions. 2020 Jun;13(6):e008649.
Zhang B, Xu H, Zhang H, Liu Q, Ye Y, Hao J, Zhao Q, Qi X, Liu S, Zhang E, Xu Y. Prognostic value of N-terminal pro–B-type natriuretic peptide in elderly patients with valvular heart disease. Journal of the American College of
Cardiology. 2020 Apr 14;75(14):1659-72.
Zhao X, Jiang L, Xu L, Tian J, Xu Y, Zhao Y, Feng X, Wu Y, Zhang Y, Wang D, Sun K. Predictive value of in-hospital white blood cell count in Chinese patients with triple-vessel coronary disease. European journal of preventive
cardiology. 2019 May;26(8):872-82.
Zhao Y*, Xu Y*, Wang Y, Li W. Two-stage design in non-randomized medical device clinical trials. Chinese Journal of Health Statistics. 2017 Dec; (6):877-880.